Search results
Where Is Amgen Headed After the Stock Surges on Obesity Drug News?
TheStreet.com· 2 days agoShares of Amgen (AMGN) are soaring higher Friday morning after the biopharma company's CEO gave a...
Amgen axes obesity asset after phase 1 results, zooms in on MariTide
FierceBiotech· 2 days agoAmgen is axing obesity candidate AMG 786 and going all in on later-stage asset MariTide. “Given the...
Coalition urges DoD to tackle obesity epidemic
Federal News Network· 2 days agoTom Temin And in this letter to Secretary Austin, you’re saying that obesity is an existential threat to the U.S. military. Courtney Manning...
So you've lost weight using Wegovy. Does that mean you can stop taking it?
San Francisco Chronicle· 3 days agoMillions of Americans who have dropped pounds and boosted their health using popular obesity drugs...
Small Bowel Microbiome Profiles Differ in Overweight/Obesity
Medscape· 2 days agoResearchers have identified significant and specific variations in the microbial universe of the...
Health Care Climbs as Amgen Surges on Obesity-Drug Plans - Health Care Roundup
Market Watch· 1 day agoHealth-care companies rose after a surprising new entrant in the obesity-drug bonanza from one biotech giant. Amgen shares surged after the biotech giant said it saw encouraging ...
Does obesity really increase your risk of dementia?
Medical Xpress· 5 days agoThe evidence linking obesity to dementia does at first appear to be convincing. For example, we know that being obese in middle age is associated with an increased risk of ...
Wegovy, an injectable medication used to treat obesity, will now be available in Canada. Here's what...
Yahoo Canada Style· 2 days agoPerspectives Wegovy users are advised to modify their diet and exercise. (Image via Getty Images)...
Amgen (AMGN) Q1 Earnings Top, Stock Up on Obesity Drug Update
Zacks via Yahoo Finance· 2 days agoAmgen (AMGN) beats first-quarter 2024 estimates for earnings and sales. Amgen is "very encouraged"...
Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market
AOL· 1 day agoAmgen's (AMGN) positive trial results update on its GLP-1 injectable for obesity, MariTide, sent its stock up more than 13% in trading Friday. CEO Bob Bradway shared a peek ...